Focus on Lung Cancer
Once you quit smoking, the benefits are immediate.
by Amanda Palmer, BA, and Benjamin Toll, PhD
Many people with cancer who smoke feel it is too late to quit smoking. The truth is it’s never too late to quit. And quitting smoking may actually improve the effectiveness of your treatments while helping you live a healthier life.
The U.S. Food and Drug Administration has approved Gilotrif (afatinib) for patients with late stage (metastatic) non-small cell lung cancer (NSCLC) whose tumors express specific types of epidermal epidermal growth factor receptor (EGFR) gene mutations, as detected by an FDA-approved test.
Different types of treatments are available for people with non-small cell lung cancer. Surgery, radiation therapy, chemotherapy, targeted therapy, laser therapy, photodynamic therapy, cryosurgery, electrocautery, and watchful waiting are the nine standard treatments used for this cancer.